Qtron Investments LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qtron Investments LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$534,524
+30.8%
5,967
+24.3%
0.10%
+30.8%
Q2 2023$408,587
+21.4%
4,799
+18.0%
0.08%
+13.0%
Q1 2023$336,462
+57.6%
4,066
+49.8%
0.07%
+53.3%
Q4 2022$213,535
+6.2%
2,7150.0%0.04%
-10.0%
Q3 2022$201,000
-26.6%
2,715
-0.9%
0.05%
-76.2%
Q4 2018$274,0002,7400.21%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders